Marc Beer Officially Joins Surgical Tool Manufacturer LumeN XT

LumeN XT has been generating a significant amount of attention in recent years. The majority of this has been focused on its proprietary surgical illumination products. This is chiefly because the company has developed a few innovative technologies that look to increase flexibility, safety, and precision in surgeries. Perhaps the most notable of these is a heat reduction mechanism that not only helps to illuminate an area further but reduces the risks that are often associated with the devices. With the foundations of future growth already built, the company is now looking to go international. As such, LumeN XT has announced that Marc Beer has joined the company as Chairman of the Board.


Beer has cultivated quite a reputation within the MedTech industry of the last two and a half decades. This has primarily been through his work with a variety of startups that he’s guided through several early growth stages. This has led each of these companies to a considerable amount of profitability. While many of these companies were focused on the United States when he first joined, Marc Beer has been able to take them global while capitalizing on a few key markets. Through this, his expertise has grown in the likes of biotechnology, pharmaceuticals, devices, and diagnostics. This experience has also been in both the commercialization and development sides of these businesses.


Perhaps the most notable of his recent positions has been with Renovia Inc. Marc Beer founded the company in 2016 to develop a range of diagnostic and treatment tools focused on pelvic floor disorders. Since then, Renovia Inc has continued to grow, with a few notable products being approved by the FDA and more already being in development. This is something that LumeN XT looks to use as it moves forward. Co-founder of the company Paul Rhyne has noted that Marc Beer’s experience will add tangible value to LumeN XT as it looks to capitalize on a growing international market. The market has primarily been driven by the need for more accurate tools that are not only safe but help to minimize how invasive a surgery can be.


Speaking about Marc Beer joining the company, Rhyne noted that the MedTech veteran has guided many businesses through a global commercial rollout that puts them on the path to profitability. This is something that he noted will be of a significant amount of value to LumeN XT. Beer has also noted that the startup is in a prime position to capitalize on the market. This is chiefly because there’s a large demand for the products that it develops. Furthermore, he highlighted the fact that the team of engineers and surgical professionals at the company have developed a stellar reputation for crafting high-quality products that meet the needs of medical professionals around the world. Learn more: